Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3JVS

Characterization of the Chk1 allosteric inhibitor binding site

3JVS の概要
エントリーDOI10.2210/pdb3jvs/pdb
関連するPDBエントリー3JVR
分子名称Serine/threonine-protein kinase Chk1, 2-[(4-tert-butyl-3-nitrophenyl)carbonyl]-N-naphthalen-1-ylhydrazinecarboxamide (3 entities in total)
機能のキーワードprotein kinase, atp-binding, cell cycle, cytoplasm, dna damage, dna repair, isopeptide bond, kinase, nucleotide-binding, nucleus, phosphoprotein, polymorphism, serine/threonine-protein kinase, transferase, ubl conjugation
由来する生物種Homo sapiens (human)
細胞内の位置Nucleus: O14757
タンパク質・核酸の鎖数1
化学式量合計31661.41
構造登録者
Chen, P. (登録日: 2009-09-17, 公開日: 2009-10-06, 最終更新日: 2024-02-21)
主引用文献Vanderpool, D.,Johnson, T.O.,Ping, C.,Bergqvist, S.,Alton, G.,Phonephaly, S.,Rui, E.,Luo, C.,Deng, Y.L.,Grant, S.,Quenzer, T.,Margosiak, S.,Register, J.,Brown, E.,Ermolieff, J.
Characterization of the CHK1 allosteric inhibitor binding site.
Biochemistry, 48:9823-9830, 2009
Cited by
PubMed Abstract: Checkpoint kinase 1 (CHK1) is a key element in the DNA damage response pathway and plays a crucial role in the S-G(2)-phase checkpoint. Inhibiting CHK1 is a therapeutic strategy involving abrogation of the G2/M mitotic checkpoint defense of tumor cells toward lethal damage induced by DNA-directed chemotherapeutic agents. To date, most CHK1 inhibition approaches have involved targeting the ATP site of this kinase. In this study, we provide crystallographic and kinetic characterization of two small molecule inhibitors that bind to an allosteric site in the proximity of the CHK1 substrate site. Analysis of kinetic and biophysical data has led to the conclusion that these small molecule allosteric site inhibitors of CHK1 are reversible and are neither ATP- nor peptide substrate-competitive. K(i) values of 1.89 and 0.15 microM, respectively, have been determined for these compounds using a mixed inhibitor kinetic analysis. Cocrystal structures of the inhibitors bound to CHK1 reveal an allosteric site, unique to CHK1, located in the C-terminal domain and consisting of a shallow groove linked to a small hydrophobic pocket. The pocket displays induced fit characteristics in the presence of the two inhibitors. These findings establish the potential for the development of highly selective CHK1 inhibitors.
PubMed: 19743875
DOI: 10.1021/bi900258v
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.9 Å)
構造検証レポート
Validation report summary of 3jvs
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon